-
1
-
-
0029821872
-
Microsatellite alterations in plasma DNA of non-small cell lung cancer patients
-
Chen XQ, Stroun M, Magnenat JL, et al. Microsatellite alterations in plasma DNA of non-small cell lung cancer patients. Nat Med 1996; 2: 1.033-1.034.
-
(1996)
Nat Med
, vol.2
, pp. 1033-1034
-
-
Chen, X.Q.1
Stroun, M.2
Magnenat, J.L.3
-
2
-
-
0029836445
-
Microsatellite alterations in serum DNA of head and neck cancer patients
-
Nawroz H, Koch W, Anker P, et al. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996; 2: 1.035-1.037.
-
(1996)
Nat Med
, vol.2
, pp. 1035-1037
-
-
Nawroz, H.1
Koch, W.2
Anker, P.3
-
3
-
-
0031904866
-
Detection of chromosome 3p alterations in serum DNA of non-small cell lung cancer patients
-
Sánchez-Céspedes M, Monzó M, Rosell R, et al. Detection of chromosome 3p alterations in serum DNA of non-small cell lung cancer patients. Ann Oncol 1998; 9: 113-116.
-
(1998)
Ann Oncol
, vol.9
, pp. 113-116
-
-
Sánchez-Céspedes, M.1
Monzó, M.2
Rosell, R.3
-
4
-
-
0032696782
-
Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: A prospect for early diagnosis
-
Sozzi G, Musso K, Ratcliffe, et al. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis. ClinCancer Res 1999; 5: 2.689-2.692.
-
(1999)
ClinCancer Res
, vol.5
, pp. 2689-2692
-
-
Sozzi, G.1
Ratcliffe, M.K.2
-
5
-
-
0032894125
-
Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients
-
Esteller M, Sánchez-Céspedes M, Rosell R, et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999; 59: 67-70.
-
(1999)
Cancer Res
, vol.59
, pp. 67-70
-
-
Esteller, M.1
Sánchez-Céspedes, M.2
Rosell, R.3
-
6
-
-
0032578509
-
Aberrant methylation of p16 is an early even in lung cancer and a potential biomarker for early diagnosis
-
Belinsky SA, Nikula KJ, Palmisano WA, et al. Aberrant methylation of p16 is an early even in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 1998; 95: 11.891-11.896.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 11891-11896
-
-
Belinsky, S.A.1
Nikula, K.J.2
Palmisano, W.A.3
-
7
-
-
0032902278
-
TP53 gene mutations in plasma DNA of cancer patients
-
Silva JM, González R, Domínguez G, et al. TP53 gene mutations in plasma DNA of cancer patients. Genes, Chromosomes Cancer 1999; 24: 160-161.
-
(1999)
Genes, Chromosomes Cancer
, vol.24
, pp. 160-161
-
-
Silva, J.M.1
González, R.2
Domínguez, G.3
-
8
-
-
0000617004
-
From the bench to the bed: The need for translation research
-
Rosell R, Carrato A. From the bench to the bed: the need for translation research. Rev Oncologia 1999; 1: 181-187.
-
(1999)
Rev Oncologia
, vol.1
, pp. 181-187
-
-
Rosell, R.1
Carrato, A.2
-
9
-
-
8544278896
-
Reduced survival in patients with stage-I non-small cell lung cancer associated with DNA replication errors
-
Rosell R, Pifarré A, Monzó M, et al. Reduced survival in patients with stage-I non-small cell lung cancer associated with DNA replication errors. In J Cancer (Pred Oncol) 1997; 74: 330-334.
-
(1997)
J Cancer (Pred Oncol)
, vol.74
, pp. 330-334
-
-
Rosell, R.1
Pifarré, A.2
Monzó, M.3
|